Sundaram Finance Limited (NSE:SUNDARMFIN)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	516,855	508,239	459,826	255,483	215,564	285,587
Market Cap Growth	10.26%	10.53%	79.98%	18.52%	-24.52%	113.63%
PE Ratio	26.71	27.04	32.02	19.24	18.37	24.51
PS Ratio	12.69	12.79	12.67	8.86	8.73	12.55
PB Ratio	3.92	3.85	4.15	2.02	1.94	3.02
P/FCF Ratio	-	-	-	-	12.30	65.17
P/OCF Ratio	-	-	-	-	12.11	63.53
Debt / Equity Ratio	3.98	3.98	4.01	2.85	2.72	3.23
Debt / FCF Ratio	-	-	-	-	17.23	69.71
Quick Ratio	-	3.81	4.41	4.00	4.32	4.33
Current Ratio	-	3.88	4.49	4.07	4.40	4.42
Asset Turnover	-	0.06	0.06	0.06	0.05	0.05
Return on Equity (ROE)	-	15.48%	15.53%	12.72%	12.62%	13.91%
Return on Assets (ROA)	-	2.69%	3.06%	2.90%	2.74%	2.68%
Earnings Yield	3.71%	3.70%	3.12%	5.20%	5.44%	4.08%
Earnings Yield	3.71%	3.70%	3.12%	5.20%	5.44%	4.08%
FCF Yield	-	-17.77%	-18.64%	-25.56%	8.13%	1.53%
Dividend Yield	0.78%	0.77%	0.73%	1.20%	1.06%	0.73%
Payout Ratio	-	17.59%	22.21%	22.38%	17.18%	14.69%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Total Shareholder Return	0.75%	0.76%	0.73%	1.19%	1.05%	0.71%

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.